Measuring CGRP in saliva to study migraine by sex and age
Tests a saliva CGRP measure in people with migraine and healthy controls.
Plain-language title generated from the registry record
Registry title: Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
Key facts
- Where
- Barcelona, SpainSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 6 and 75 years old?
Source: NCT06674772, who can take part
Where in Spain
- Vall d'Hebron University HospitalBarcelona, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Hospital Universitari Vall d'Hebron Research Institute
- Trial code
- NCT06674772
- Record updated
- 13 November 2024
- Original description
Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to visit the study center for sample collection. A sample of blood and saliva will be collected in order to measure CGRP levels and DNA and hormone testing.Read full original descriptionShow less
Fenotipado Molecular De Pacientes Con Migraña Según Edad Y Sexo a Través De La Cuantificación De CGRP En Saliva Para Realizar Medicina De Precisión: Estudio FAST
Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to visit the study center for sample collection. A sample of blood and saliva will be collected in order to measure CGRP levels and DNA and hormone testing.
Inclusion: Migraine patients according to ICHD-3 criteria; Healthy controls paired to patient age and sex, without headache and without first degree family history of headache.
Exclusion: Abuse or dependence to tobacco, alcohol or any drug in the previous 12 months before the enrollment; Presence of any major medical or neurological illness; Presence of any salivary gland malfunction; Active migraine preventive treatment; Pregnant or breastfeeding female.